Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Novel BK channel modulators for stroke reported by Bristol-Myers Squibb

Aug. 31, 1999

AHP investigates oxazole derivatives with potential in treating various CNS disorders

Aug. 31, 1999

Novel emopamil binding site inhibitors synthesized and evaluated at AstraZeneca

Aug. 31, 1999

New IGT compound shows promise in stroke therapy

Aug. 31, 1999

Interneuron completes patient enrollment in ECCO 2000

Aug. 31, 1999

Cerebrus researches GABA-A ligands for treating CNS disorders

Aug. 30, 1999

ACS presentation for PD-176078, a novel calcium channel blocker with analgesic activity

Aug. 27, 1999

University of Minnesota team describes potent and selective kappa-opioid antagonist at ACS

Aug. 27, 1999

Fujisawa prepares novel series of vasopressin antagonists

Aug. 27, 1999

More selective GABA-A receptor ligands prepared and evaluated at Merck & Co.

Aug. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...